iShares Biotechnology ETF

NAV as of Dec 07, 2021 $151.02
52 WK: 145.24 - 176.23
1 Day NAV Change as of Dec 07, 2021 5.79 (3.98%)
NAV Total Return as of Dec 07, 2021 YTD: -0.09%

Fees as stated in the prospectus Expense Ratio: 0.45%

Overview

Why IBB?

1. Exposure to U.S. companies in the biotechnology industry

2. Targeted access to biotechnology stocks

3. Use to express an industry view

INVESTMENT OBJECTIVE

The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.

Next: Previous:

Performance

Growth of Hypothetical $10,000

Performance chart data not available for display.

Growth of Hypothetical $10,000
Historical NAVs

iShares Biotechnology ETF ($)

The Hypothetical Growth of $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted, and numbers may reflect small variances due to rounding. Standardized performance and performance data current to the most recent month end may be found in the Performance section.